Rom E. Eliaz
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 4
- Glycosylation and Glycoproteins Research 2
-
- biodegradable polymer synthesis and properties 2
- Co-authors
- Francis C. Szoka (4 shared papers)Joseph Kost (5 shared papers)Shlomo Nir (2 shared papers)Cornelia Marty (1 shared paper)David Wallach (1 shared paper)Eli Eyal (3 shared papers)Victor Abler (2 shared papers)Robert A. Hauser (1 shared paper)
- Journals
- Journal of Biomedical Materials Research (2 papers)Pharmaceutical Research (1 paper)Israel Journal of Chemistry (1 paper)Drug and Alcohol Dependence (1 paper)Cytokine (1 paper)
- Partner nations
- IsraelUnited StatesSwitzerland
In The Last Decade
Rom E. Eliaz
12 papers receiving 767 citations
Peers
Comparison fields: 5 of 91
- Pharmaceutical Science 178
- Biomaterials 336
- Molecular Medicine 79
- Cell Biology 112
- Molecular Biology 363
Countries citing papers authored by Rom E. Eliaz
This map shows the geographic impact of Rom E. Eliaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rom E. Eliaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rom E. Eliaz more than expected).
Fields of papers citing papers by Rom E. Eliaz
This network shows the impact of papers produced by Rom E. Eliaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rom E. Eliaz. The network helps show where Rom E. Eliaz may publish in the future.
Co-authors
The 25 scholars most cited alongside Rom E. Eliaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. | 2001 | 298 |
| 2 | 2000 | 141 | |
| 3 | 2004 | 127 | |
| 4 | 2016 | 49 | |
| 5 | 2000 | 44 | |
| 6 | 2002 | 39 | |
| 7 | 2016 | 32 | |
| 8 | 2004 | 28 | |
| 9 | 1996 | 18 | |
| 10 | 2016 | 15 | |
| 11 | 2000 | 7 | |
| 12 | 2005 | 1 |
About Rom E. Eliaz
Rom E. Eliaz is a scholar working on Molecular Biology, Biomaterials, Genetics, Cellular and Molecular Neuroscience and Neurology, having authored 12 papers that have together received 799 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (4 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Virus-based gene therapy research (2 papers), Glycosylation and Glycoproteins Research (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), biodegradable polymer synthesis and properties (2 papers), Bone Tissue Engineering Materials (2 papers) and Neurological disorders and treatments (2 papers). The work is most often cited by research in Pharmaceutical Science (178 citations), Biomaterials (336 citations), Molecular Medicine (79 citations), Cell Biology (112 citations) and Molecular Biology (363 citations). Rom E. Eliaz has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Francis C. Szoka, Joseph Kost, Shlomo Nir, Cornelia Marty, David Wallach, Eli Eyal, David Wallach, Victor Abler, Robert A. Hauser and David J. McCann. Their work appears in journals such as Journal of Biomedical Materials Research, Pharmaceutical Research, Israel Journal of Chemistry, Drug and Alcohol Dependence and Cytokine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.